Eagle Pharmaceuticals shares owned by Bank of New York Mellon
Quarter-by-quarter ownership of Eagle Pharmaceuticals (EGRX) shares owned by Bank of New York Mellon
from 13F filings
Historical chart of Bank of New York Mellon investment in Eagle Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Eagle Pharmaceuticals held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Eagle Pharmaceuticals by Bank of New York Mellon
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $185k | 35k | 5.24 |
| 2023-12-31 | $219k | 42k | 5.23 |
| 2023-09-30 | $997k | 63k | 15.77 |
| 2023-06-30 | $1.2M | 64k | 19.44 |
| 2023-03-31 | $3.2M | 113k | 28.37 |
| 2022-12-31 | $3.5M | 120k | 29.23 |
| 2022-09-30 | $2.8M | 106k | 26.67 |
| 2022-06-30 | $4.6M | 103k | 44.42 |
| 2022-03-31 | $5.7M | 116k | 49.49 |
| 2021-12-31 | $7.5M | 125k | 60.00 |
| 2021-09-30 | $7.0M | 126k | 55.78 |
| 2021-06-30 | $4.9M | 115k | 42.80 |
| 2021-03-31 | $5.0M | 120k | 41.74 |
| 2020-12-31 | $6.0M | 128k | 46.57 |
| 2020-09-30 | $5.5M | 130k | 42.49 |
| 2020-06-30 | $5.5M | 113k | 48.28 |
| 2020-03-31 | $5.1M | 110k | 45.99 |
| 2019-12-31 | $7.0M | 117k | 60.08 |
| 2019-09-30 | $7.0M | 123k | 56.57 |
| 2019-06-30 | $7.2M | 129k | 55.68 |
| 2019-03-31 | $6.7M | 133k | 50.49 |
| 2018-12-31 | $5.5M | 137k | 40.28 |
| 2018-09-30 | $12M | 178k | 69.33 |
| 2018-06-30 | $12M | 154k | 75.66 |
| 2018-03-31 | $7.8M | 147k | 52.68 |
| 2017-12-31 | $8.3M | 155k | 53.42 |
| 2017-06-30 | $9.2M | 117k | 78.88 |
| 2017-03-31 | $9.6M | 116k | 82.93 |
| 2016-12-31 | $9.3M | 117k | 79.33 |
| 2016-09-30 | $6.5M | 93k | 70.00 |
| 2016-06-30 | $1.6M | 42k | 38.76 |